Withings, pioneers of the connected health revolution, begins United States sales of ScanWatch, its award-winning and most advanced health wearable to date.
Available from Withings.com, Amazon, and Best Buy Stores, from November 9, its state-of-the-art technology has the potential to help users lead healthier lives with the ability to monitor heart rate, atrial fibrillation through electrocardiogram, blood oxygen levels through oxygen saturation, sleep, and physical activity.
ScanWatch has been cleared by the Food and Drug Administration to both record electrocardiogram and oxygen saturation measurements. Developed with cardiologists and sleep experts, ScanWatch has been validated in two clinical studies and is designed with a stainless-steel case and durable sapphire glass watch face that combines both analog hands as well as a large digital display. Priced at $279 (38mm) and $299 (42 mm), it comes in a choice of black or white faces and a host of medical monitoring and health tracking capacities.
These include:
- Clinically validated detection of atrial fibrillation by electrocardiogram
- Heart Rate scan every 10 minutes using a Photoplethysmography sensor
- Clinically validated oxygen saturation
- Automatic activity tracking (walking, running, swimming, distance, and calories burned)
- Training mode with up to 30 activities (measurement of distance, pace, and altitude)
- Fitness level assessment with volume of oxygen Max
- Sleep monitoring (length, quality, sleep phases)
- Smart smartphone notifications
- Altimeter records floors traveled
- Water resistant up to 5 atmospheres
- Up to 30 days battery life
“ScanWatch received three CES Innovation Awards when it was announced and we are now thrilled to bring it to the United States following FDA clearance” said Mathieu Letombe, Chief executive officer of Withings. “At Withings our core mission is to create beautiful devices people choose to use and wear every day so the medical and wellness data they provide can make meaningful impacts on their lives. ScanWatch has been clinically validated to detect AFib. It is our most ambitious watch to date and has the potential to help millions of people track medical and wellness data.”
